Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05134922 |
Title | Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009 |
Recruitment | Available |
Gender | female |
Phase | Expanded access |
Variant Requirements | No |
Sponsors | Celcuity, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama at Birmingham | AVAILABLE | Birmingham | Alabama | 35233 | United States | Details |
University of Michigan | AVAILABLE | Ann Arbor | Michigan | 48109 | United States | Details |
Ohio State University Comprehensive Cancer Center | AVAILABLE | Columbus | Ohio | 43210 | United States | Details |
The University of Texas MD Anderson Cancer Center | AVAILABLE | Houston | Texas | 77030 | United States | Details |
Seattle Cancer Care Alliance | AVAILABLE | Seattle | Washington | 98109 | United States | Details |